Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh (DHER34) Price & Analysis

DHER34 Stock Chart & Stats

R$45.19-R$0.51(-1.12%)

At close: Oct 30 4:00 PM EDT

Day’s Range: BRL 44.89 - BRL 45.29
52-Week Range: BRL 28.02 - BRL 47.95
Previous Close: BRL 45.70
Volume: N/A
Average Volume (3M): 2,218
Market Cap: BRL 888.81B
Enterprise Value: BRL 936.78B
Total Cash (Recent Filing): N/A
Total Debt (Recent Filing): N/A
Price to Earnings (P/E): 41081.8
Beta: -0.20
Next Earnings: Jan 27, 2027
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: 0.41%

Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh News

Danaher price target raised to $270 from $255 at BofA

BofA raised the firm’s price target on Danaher (DHR) to $270 from $255 and keeps a Buy rating on the shares. Management provided initial 2027 framing of 4%-5% core revenue

1w agoDHR DAP

Danaher price target raised to $270 from $255 at TD Cowen

TD Cowen raised the firm’s price target on Danaher (DHR) to $270 from $255 and keeps a Buy rating on the shares. The firm said the company’s new CEO Julie

1w agoDHR DAP

Danaher price target raised to $275 from $250 at Goldman Sachs

Goldman Sachs raised the firm’s price target on Danaher (DHR) to $275 from $250 and keeps a Buy rating on the shares. Published first on TheFly – the ultimate source

1w agoDHR DAP

Danaher price target raised to $270 from $250 at JPMorgan

JPMorgan raised the firm’s price target on Danaher (DHR) to $270 from $250 and keeps an Overweight rating on the shares. Published first on TheFly – the ultimate source for

1w agoDHR DAP

Danaher price target raised to $260 from $220 at Stifel

Stifel raised the firm’s price target on Danaher (DHR) to $260 from $220 and keeps a Buy rating on the shares. Non-respiratory core growth came in a bit above expectations

1w agoDHR DAP

Danaher price target raised to $254 from $246 at Baird

Baird raised the firm’s price target on Danaher (DHR) to $254 from $246 and keeps an Outperform rating on the shares. The firm updated its model following Q3 results. Published

1w agoDHR DAP

Danaher price target raised to $270 from $230 at Citi

Citi analyst Patrick Donnelly raised the firm’s price target on Danaher (DHR) to $270 from $230 and keeps a Buy rating on the shares following the Q3 report. The firm

1w agoDHR DAP

Danaher price target raised to $260 from $255 at Barclays

Barclays raised the firm’s price target on Danaher (DHR) to $260 from $255 and keeps an Overweight rating on the shares following the Q3 report. The firm sees “plenty of

1w agoDHR DAP

Midday Fly By: SpaceX reports Q3 beat, will consider Tesla merger

The major averages were higher near noon, supported by upbeat results from SpaceX and Super Micro Computer that revived optimism around AI demand. In addition to the space technology company

1w agoT ZM

Morning Movers: Super Micro surges after Q1 pre-announcement

Stock futures are pointing higher as investors weigh corporate earnings against oil prices that are climbing again. Brent crude is above $110 a barrel and West Texas Intermediate near $99

1w agoT PM

Danaher: Temporary Bioprocessing Setback, Structural Story Intact; Buy Rating and $220 Price Target Reiterated

Danaher, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Kallum Titchmarsh from Morgan Stanley maintained a Buy rating on the stock and has a $220.00

3M agoDHR DAP

Goldman’s Koslosky Reiterates Buy on Danaher as Q2 Beat and Tools Recovery Offset Trimmed 2024 Core Growth Guidance

Goldman Sachs analyst Evie Koslosky has maintained their bullish stance on DHR stock, giving a Buy rating today. Evie Koslosky has given his Buy rating due to a combination of

3M agoDHR DAP

Danaher: Analyst Reaffirms Buy, Lifts Price Target to $255 on Long-Term Bioprocessing Upside and Life Sciences Strength

Morgan Stanley analyst Kallum Titchmarsh maintained a Buy rating on Danaher yesterday and set a price target of $255.00. Kallum Titchmarsh has given his Buy rating due to a combination

3M agoDHR DAP

Margin Resilience and Life Science Recovery Support Buy Rating as Danaher Price Target Remains Unchanged at $230

Danaher, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Patrick B Donnelly from Citi maintained a Buy rating on the stock and has a $230.00

3M agoDHR DAP

DHER34 FAQ

What was Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh’s price range in the past 12 months?

Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh lowest stock price was R$28.02 and its highest was R$47.95 in the past 12 months.

What is Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh’s market cap?

Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh’s market cap is R$888.81B.

When is Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh’s earnings last quarter?

Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh released its earnings results on Oct 21, 2026. The company reported R$0 earnings per share for the quarter.

Is Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh pay dividends?

Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh does not currently pay dividends.

What is Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh’s EPS estimate?

Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh have?

Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh has 19,701,227,000 shares outstanding.

What happened to Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh’s price movement after its last earnings report?

Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh reported an EPS of R$0 in its last earnings report. Following the earnings report the stock price went up 1.424%.

Which hedge fund is a major shareholder of Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh?

Currently, no hedge funds are holding shares in BR:DHER34

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh (DHER34) Earnings & Revenues

Historic Earnings Reports

Technical Analysis

Overall Consensus

Indicator	Bullish	Neutral	Bearish
Overall Consensus	14	3	5
Technical Analysis	2	3	5
Moving Averages	12	0	0

Technical Analysis >

Similar Stocks

Stocks similar to BR:DHER34
Company	Price & Change	Follow
BR:ABTT34Abbott Laboratories Shs Unsponsored Brazilian Depository Receipts Repr 0.083333333 S
BR:I1SR34Intuitive Surgical, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh
BR:MDTC34Medtronic plc Unsponsored Brazilian Depository Receipt Repr 1/2 Sh
BR:MMMC343M Company Shs Unsponsored Brazilian Depository Receipts Repr 1/4 Sh
BR:S1YK34Stryker Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh

Compare BR:DHER34 Stocks >

Popular Stocks

Popular Stocks
Company	Price & Change	Follow
NVDANvidia
AAPLApple
MSFTMicrosoft

Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh stock analysis

Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh (DHER34) Price & Analysis

DHER34 Stock Chart & Stats

Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh News

Danaher price target raised to $270 from $255 at BofA

Danaher price target raised to $270 from $255 at TD Cowen

Danaher price target raised to $275 from $250 at Goldman Sachs

Danaher price target raised to $270 from $250 at JPMorgan

Danaher price target raised to $260 from $220 at Stifel

Danaher price target raised to $254 from $246 at Baird

Danaher price target raised to $270 from $230 at Citi

Danaher price target raised to $260 from $255 at Barclays

Midday Fly By: SpaceX reports Q3 beat, will consider Tesla merger

Morning Movers: Super Micro surges after Q1 pre-announcement

Danaher: Temporary Bioprocessing Setback, Structural Story Intact; Buy Rating and $220 Price Target Reiterated

Goldman’s Koslosky Reiterates Buy on Danaher as Q2 Beat and Tools Recovery Offset Trimmed 2024 Core Growth Guidance

Danaher: Analyst Reaffirms Buy, Lifts Price Target to $255 on Long-Term Bioprocessing Upside and Life Sciences Strength

Margin Resilience and Life Science Recovery Support Buy Rating as Danaher Price Target Remains Unchanged at $230

DHER34 FAQ

Danaher Corp Shs Unsponsored Brazilian Depository Receipt Repr 0.035714285 Sh (DHER34) Earnings & Revenues

Technical Analysis

Overall Consensus

Similar Stocks

Popular Stocks

Become an Expert with TipRanks Premium